![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-issues-voluntary-nationwide-recall-one-lot-anagrelide-capsules-usp-05-mg-due-dissolution-test
https://www.pharmacompass.com/pdf/news/torrent-pharmaceuticals-limited-issues-voluntary-nationwide-recall-of-anagrelide-capsules-1607675919.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-9-2020-1607497312.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-25-2019-1569469631.pdf
https://www.pharmacompass.com/pdf/news/mylans-anagrelide-receives-approval-in-europe-1519884132.pdf
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/12/news_detail_002867.jsp&mid=WC0b01ac058004d5c1